In this group, of the 318 patients who were diagnosed with PTC [including 249 women (78.3%) and 69 men (21.7%), with a mean age at diagnosis of 38±10 years (range, 15–54 years) and a mean tumor size of 1.7±0.8 cm], 232 patients (51.6%) were positive for BRAF-V600E mutation. The gene discussed is BRAF; the disease is neoplasm.